US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 0.733
  • +0.012+1.73%
Close Nov 29 13:00 ET
  • 0.769
  • +0.036+4.96%
Post 17:01 ET
28.97MMarket Cap-1979P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MiNK Therapeutics Q3 2024 Earnings Date

Currency：USDNov 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.08
-0.05
+0.03
Beat Est.
+46.70%
+66.67%
+37.42%
Analyst Rating
No Data

MiNK Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 14, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 14, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

MiNK Therapeutics Earnings Reports

  • MiNK Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 15 05:14

  • MiNK Therapeutics | 8-K: MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update

    Nov 14 20:07

  • MiNK Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 04:11

  • MiNK Therapeutics | 8-K: MiNK Reports Second Quarter 2024 Results and Business Update

    Aug 13 19:02

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data